DMAAR Drugs Made In America Acquisition Corp. - Rights
DMAAR Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
DMAAR Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Financial Health Debt, liquidity, solvency — balance sheet strength
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Balance Sheet 12
| Metric | Trend | 2025 |
|---|---|---|
| Cash & Equivalents | $6.1K | |
| Prepaid Expense | $6.1K | |
| Current Assets | $12.2K | |
| Total Assets | $240M | |
| Accounts Payable | $222.2K | |
| Current Liabilities | $376.2K | |
| Total Liabilities | $7M | |
| Common Stock | $1.1K | |
| Retained Earnings | $-7M | |
| Stockholders' Equity | $-7M | |
| Liabilities + Equity | $240M | |
| Shares Outstanding | 10,717,143 |
Income Statement 6
| Metric | Trend | Q2 2026 | Q1 2026 |
|---|---|---|---|
| SG&A Expense | $136.9K | $143.3K | |
| Operating Income | $-136.9K | $-143.3K | |
| Interest Income | $2M | $2M | |
| Other Non-op | $2M | $2M | |
| Net Income | $2M | $2M | |
| EBITDA | $-136.9K | $-143.3K |
Balance Sheet 14
| Metric | Trend | Q2 2026 | Q1 2026 |
|---|---|---|---|
| Cash & Equivalents | $20.3K | $14.9K | |
| Prepaid Expense | $48.9K | · | |
| Current Assets | $69.2K | $14.9K | |
| Total Assets | $147M | $242M | |
| Accounts Payable | $254.4K | $238.2K | |
| Short-term Debt | $350.0K | $100.0K | |
| Current Liabilities | $3M | $492.2K | |
| Total Liabilities | $9M | $7M | |
| Total Debt | $350.0K | $100.0K | |
| Common Stock | $1.1K | $1.1K | |
| Retained Earnings | $-7M | $-7M | |
| Stockholders' Equity | $-7M | $-7M | |
| Liabilities + Equity | $147M | $242M | |
| Shares Outstanding | 10,717,143 | 10,717,143 |
Cash Flow 2
| Metric | Trend | Q2 2026 | Q1 2026 |
|---|---|---|---|
| Operating Cash Flow | $-244.6K | $-91.2K | |
| Financing Cash Flow | $-98M | $100.0K |
Profitability 2
| Metric | Trend | Q2 2026 | Q1 2026 |
|---|---|---|---|
| ROA | 0.90% | 0.83% | |
| ROE | -23.7% | -27.1% |
Liquidity & Solvency 3
| Metric | Trend | Q2 2026 | Q1 2026 |
|---|---|---|---|
| Current Ratio | 0.0 | 0.0 | |
| Quick Ratio | 0.0 | 0.0 | |
| Debt / Equity | -0.0 | -0.0 |
Valuation (TTM) 6
| Metric | Trend | Q2 2026 | Q1 2026 |
|---|---|---|---|
| Net Income TTM | $8M | $8M | |
| Market Cap | $1M | $659.1K | |
| Enterprise Value | $1M | $744.2K | |
| P/B | -0.2 | -0.1 | |
| P / Cash Flow | · | -7.2 | |
| EV / EBITDA | -10.6 | -5.2 |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 31 filers · $1.5M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 2 (-3 vs prior Q) | 8 (+5 vs prior Q) | 3 (-3 vs prior Q) | 8 (-2 vs prior Q) | -2.8M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Polar Asset Management Partners Inc. | $209,000 | 1,900,000 | 13.70% | Shares |
| ATW SPAC MANAGEMENT LLC | $123,918 | 570,000 | 8.13% | Shares |
| Linden Advisors LP | $97,750 | 850,000 | 6.41% | Shares |
| MANGROVE PARTNERS IM, LLC | $93,500 | 850,000 | 6.13% | Shares |
| TORONTO DOMINION BANK | $88,000 | 800,000 | 5.77% | Shares |
| Hudson Bay Capital Management LP | $83,459 | 758,719 | 5.47% | Shares |
| CLEAR STREET LLC | $80,785 | 672,087 | 5.30% | Shares |
| Clear Street Group Inc. | $78,220 | 711,088 | 5.13% | Shares |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | $77,346 | 857,493 | 5.07% | Shares |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | $62,700 | 417,998 | 4.11% | Shares |
| BOOTHBAY FUND MANAGEMENT, LLC | $58,289 | 529,898 | 3.82% | Shares |
| Alpine Global Management, LLC | $55,000 | 500,000 | 3.61% | Shares |
| LMR Partners LLP | $55,000 | 500,000 | 3.61% | Shares |
| Westchester Capital Management, LLC | $52,243 | 474,934 | 3.43% | Shares |
| WOLVERINE ASSET MANAGEMENT LLC | $51,885 | 471,683 | 3.40% | Shares |
| WHITEBOX ADVISORS LLC | $44,000 | 400,000 | 2.89% | Shares |
| AQR Arbitrage LLC | $37,232 | 372,322 | 2.44% | Shares |
| Shaolin Capital Management LLC | $33,000 | 300,000 | 2.16% | Shares |
| CSS LLC/IL | $27,500 | 31,250 | 1.80% | Shares |
| Context Capital Management, LLC | $22,112 | 201,016 | 1.45% | Shares |
| MIZUHO SECURITIES USA LLC | $20,990 | 209,897 | 1.38% | Shares |
| Radcliffe Capital Management, L.P. | $16,543 | 143,911 | 1.08% | Shares |
| DLD Asset Management, LP | $13,925 | 126,594 | 0.91% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $13,165 | 119,686 | 0.86% | Shares |
| Periscope Capital Inc. | $8,250 | 75,000 | 0.54% | Shares |
| Lineage Point Capital LP | $5,500 | 50,000 | 0.36% | Shares |
| GABELLI FUNDS LLC | $5,423 | 49,300 | 0.36% | Shares |
| GABELLI & Co INVESTMENT ADVISERS, INC. | $5,291 | 48,100 | 0.35% | Shares |
| READYSTATE ASSET MANAGEMENT LP | $3,432 | 31,200 | 0.23% | Shares |
| T3 Companies, LLC | $1,650 | 15,000 | 0.11% | Shares |
| UBS Group AG | $12 | 108 | 0.00% | Shares |